Vaccine
|
n/N(%)
|
95% CI
|
---|
DTaP-IPV-Hib
| | |
≥ 2 doses at 6 months
|
1.147/1.297 (88.4%)
|
86.7% - 90.2%
|
≥ 3 doses at 12 months
|
891/1.008 (88.4%)
|
86.4% - 90.4%
|
PCV
| | |
≥ 1 dose at 6 months
|
1.012/1.325 (77.1%)
|
74.8% - 79.3%
|
≥ 2 doses at 12 months
|
785/995 (78.9%)
|
76.4% - 81.4%
|
MCC
| | |
≥ 1 dose at 6 months
|
518/1.279 (40.5%)
|
37.8% - 43.2%
|
HepB
| | |
≥ 1 dose at 6 months
|
934/1.353 (69.0%)
|
66.6% - 71.5%
|
≥ 3 doses at 12 months
|
575/746 (77.1%)
|
74.1% - 80.1%
|
MMR*
|
287/356 (80.6%)
|
76.3% - 84.1%
|
Varicella*
|
308/352 (87.5%)
|
83.8% - 91.2%
|
Rotavirus (2 doses)
|
152/1.475 (10.3%)
|
8.8% - 11.9%
|
HAV (one dose at 24 months)
|
64/151 (42.4%)
|
34.5% - 50.3%
|
- *Since according to NIP MMR and varicella should be administered at 12-15 months, children ≥17 months were evaluated.
- DTaP = diphteria, tetanus and acellular pertussis vaccine.
- IPV = inactivated polio vaccine.
- Hib = conjugated haemophilus influenzae type B vaccine.
- MCC = meningococcal serotype C conjugated vaccine.
- HepB = hepatitis B vaccination.
- MMR = measles, mumps and rubella vaccine.
- HAV = hepatitis A vaccine.